Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry

Journal of Proteome Research

Volumn 8, Issue 9, 2009, Pages 4216-4224

  Yeong, Hee Ahn ^a   Ji, Yeon Lee ^a   Ju, Yeon Lee ^a   Kim, Yong Sam ^c   Jeong, Heon Ko ^c   Jong, Shin Yoo ^a,b  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Aberrant glycoform; Anti peptide antibody; L PHA; Peptide quantitation; SISCAPA; TIMP1

Indexed keywords

GLYCOPROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PHYTOHEMAGGLUTININ; STABLE ISOTOPE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOAFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUTATION; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY;

ANTIBODIES, IMMOBILIZED; COLONIC NEOPLASMS; GLYCOPEPTIDES; GLYCOPROTEINS; HUMANS; ISOTOPE LABELING; LINEAR MODELS; MASS SPECTROMETRY; MODELS, MOLECULAR; PHYTOHEMAGGLUTININS; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 70349932824     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900269s     Document Type: Article

References (19)

1. Orntoft, T. F.; Vestergaard, E. M. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999, 20, 362-371. (Pubitemid 29125024)
2. Hakomori, S. Inaugural Article: The glycosynapse. Proc. Natl. Acad. Sci. U.S.A 2002, 99, 225-232.
3. Choudhury, A.; Moniaux, N.; Ulrich, A. B.; Schmied, B. M. MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. Br. J. Cancer 2004, 90, 657-664.
4. Dennis, J. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236, 582-585.
5. Barrabés, S.; Pagès-Pons, L.; Radcliffe, C. M.; Tabarés, G.; Fort, E.; Royle, L.; Harvey, D. J.; Moenner, M.; Dwek, R. A.; Rudd, P. M.; De Llorens, R.; Peracaula, R. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 2007, 17, 388-400. (Pubitemid 46432010)
6. Zhao, J.; Qiu, W.; Simeone, D. M.; Lubman, D. M. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J. Proteome Res. 2007, 6, 1126-1138.
7. Wulfkuhle, J. D.; Liotta, L. A.; Petricoin, E. F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 2003, 3, 267-275. (Pubitemid 37328862)
8. Ihara, S.; Miyoshi, E.; Ko, J. H.; Murata, K.; Nakahara, S.; Honke, K.; Dickson, R. B.; Lin, C. Y.; Taniguchi, N. Prometastatic effect of Nacetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J. Biol. Chem. 2002, 277, 16960-16967. (Pubitemid 34967724)
9. Guo, H.-B.; Lee, I.; Kamar, M.; Akiyama, S. K.; Pierce, M. Aberrant N-glycosylation of β1 integrin causes reduced R5β1 integrin clustering and stimulates cell migration. Cancer Res. 2002, 62, 6837-6845.
10. Kim, Y.-S.; Hwang, S. Y.; Kang, H.-Y.; Sohn, H.; Oh, S.; Kim, J. Y.; Yoo, J. S.; Kim, Y. H.; Kim, C. H.; Jeon, J. H.; Lee, J. M.; Kang, H. A.; Miyoshi, E.; Taniguchi, N.; Yoo, H. S.; Ko, J. H. Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol. Cell. Proteomics 2008, 7, 1-14.
11. Cummings, R. D.; Kornfeld, S. Characterization of the structural determinants required for the high affinity interaction of asparagine- linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J. Biol. Chem. 1982, 257, 11230-11234.
12. Abbott, K. L.; Aoki, K.; Lim, J. M.; Porterfield, M.; Johnson, R.; O'Regan, R. M.; Wells, L.; Tiemeyer, M.; Pierce, M. Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 2008, 7, 1470-1480.
13. Kim, Y. S.; Son, O. L.; Lee, J. Y.; Kim, S. H.; Oh, S.; Lee, Y. S.; Kim, C. H.; Yoo, J. S.; Lee, J. H.; Miyoshi, E.; Taniguchi, N.; Hanash, S. M.; Yoo, H. S.; Ko, J. H. Lectin precipitation using phytohemagglutinin- L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. Proteomics 2008, 8, 3229-3235.
14. Anderson, N. L.; Anderson, N. G.; Haines, L. R.; Hardie, D. B.; Olafson, R. W.; Pearson, T. W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Proteome Res. 2004, 3, 235-244.
15. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
16. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2229.
17. McKay, M. J.; Sherman, J.; Laver, M. T.; Baker, M. S.; Clarke, S. J.; Molloy, M. P. The development of multiple reaction monitoring assays for liver-derived plasma proteins. Proteomics Clin. Appl. 2007, 1, 1570-1581.
18. Whiteaker, J. R.; Zhao, L.; Zhang, H. Y.; Feng, L. C.; Piening, B. D.; Anderson, L.; Paulovich, A. G. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem. 2007, 362, 44-54.
19. Holten-Andersen, M. N.; Murphy, G.; Nielsen, H. J.; Pedersen, A. N.; Christensen, I. J.; Høyer-Hansen, G.; Brünner, N.; Stephens, R. W. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br. J. Cancer 1999, 80, 495-503. (Pubitemid 29213206)